A British Journal of Cancer study examines how neuroblastoma balances replication stress with genome stability across chromosome 17q. The paper focuses on how this balance may help explain why neuroblastoma behavior varies widely across patients, ranging from treatment-responsive tumors to aggressive cases with rapid spread and recurrence. By tying replication stress responses to stability mechanisms at a specific genomic region, the authors provide a route toward understanding heterogeneity in tumor progression. Chromosome 17q has been implicated in neuroblastoma outcomes, and the study’s emphasis on mechanistic coupling sharpens the biology behind that association. For clinical and translational programs, the findings point to potential biomarker or target strategies aimed at the stress-stability axis, which could complement existing risk stratification approaches.